Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Armstrong

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Forensic Sciences|August 20, 2004
The evaluation of the extent of transporting or "tracking" an identifiable ignitable liquid (gasoline) throughout fire scenes during the investigative processAndrew Armstrong, Vytenis Babrauskas, Douglas L Holmes, et al.
Journal of Pathogens|July 24, 2014
Prevalence of Multiple Antibiotic Resistant Infections in Diabetic versus Nondiabetic WoundsUrvish Trivedi, Shamini Parameswaran, Andrew Armstrong, et al.
Plos One|July 14, 2012
Locomotion of C. elegans: a piecewise-harmonic curvature representation of nematode behaviorVenkat Padmanabhan, Zeina S Khan, Deepak E Solomon, et al.
Journal of Food Protection|May 5, 2019
A Canadian Comparative Study of Modified Versions of the "FDA" and "USDA" Methods for the Detection of Listeria monocytogenesDonald W Warburton, Jeffrey M Farber, Andrew Armstrong, et al.
Biomedicines|July 2, 2021
Multiplex Patient-Based Drug Response Assay in Pancreatic Ductal AdenocarcinomaAndrew Armstrong, Muhammad R Haque, Sina Mirbagheri, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2015
A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancerMaha Hussain, Dana Rathkopf, Glenn Liu, et al.
Research Square|July 10, 2026
Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancerAndrew Armstrong, Tara Seibert, Jane McKenzie, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2022
Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPERAnthony M Joshua, Andrew Armstrong, Megan Crumbaker, et al.
Research Square|August 23, 2023
Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaborationTanya Dorff, Zeynep Zengin, Nicholas Henderson, et al.
European Urology Oncology|May 18, 2019
Consensus Statement on Circulating Biomarkers for Advanced Prostate CancerSemini Sumanasuriya, Aurelius Omlin, Andrew Armstrong, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Forensic Sciences|August 20, 2004
The evaluation of the extent of transporting or "tracking" an identifiable ignitable liquid (gasoline) throughout fire scenes during the investigative processAndrew Armstrong, Vytenis Babrauskas, Douglas L Holmes, et al.
Journal of Pathogens|July 24, 2014
Prevalence of Multiple Antibiotic Resistant Infections in Diabetic versus Nondiabetic WoundsUrvish Trivedi, Shamini Parameswaran, Andrew Armstrong, et al.
Plos One|July 14, 2012
Locomotion of C. elegans: a piecewise-harmonic curvature representation of nematode behaviorVenkat Padmanabhan, Zeina S Khan, Deepak E Solomon, et al.
Journal of Food Protection|May 5, 2019
A Canadian Comparative Study of Modified Versions of the "FDA" and "USDA" Methods for the Detection of Listeria monocytogenesDonald W Warburton, Jeffrey M Farber, Andrew Armstrong, et al.
Biomedicines|July 2, 2021
Multiplex Patient-Based Drug Response Assay in Pancreatic Ductal AdenocarcinomaAndrew Armstrong, Muhammad R Haque, Sina Mirbagheri, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2015
A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancerMaha Hussain, Dana Rathkopf, Glenn Liu, et al.
Research Square|July 10, 2026
Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancerAndrew Armstrong, Tara Seibert, Jane McKenzie, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2022
Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPERAnthony M Joshua, Andrew Armstrong, Megan Crumbaker, et al.
Research Square|August 23, 2023
Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaborationTanya Dorff, Zeynep Zengin, Nicholas Henderson, et al.
European Urology Oncology|May 18, 2019
Consensus Statement on Circulating Biomarkers for Advanced Prostate CancerSemini Sumanasuriya, Aurelius Omlin, Andrew Armstrong, et al.
Pageof 3